Self- Acupressure for Blood Pressure and Well-Being in Hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares real self-acupressure, sham acupressure, and usual care for adults with primary hypertension. Participants apply acupressure at HT7, LI4, PC6, and EX3 under nurse guidance for two weeks. Outcomes include changes in blood pressure, perceived stress, and overall well-being. The study is conducted at a Family Health Center in Duzce, Turkey, and requires Turkish literacy and consent. It excludes people with secondary hypertension, recent major cardiovascular events, skin issues at the pressure sites, and other conflicting conditions or concurrent trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Aged 18-65 years
2. Diagnosed with primary hypertension (Stage 1 or 2)
3. Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg
4. Taking antihypertensive medication
5. Able to understand and communicate in Turkish
6. Willing to provide written informed consent

Exclusion Criteria:

1. Secondary hypertension
2. Pregnancy or lactation
3. Severe cardiovascular disease (heart failure, myocardial infarction within 6 months)
4. Stroke history within 6 months
5. Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3)
6. Peripheral neuropathy affecting sensation
7. Current use of anticoagulant therapy
8. Participation in another clinical trial within 30 days

Where it's running

• A Family Health Center in Duzce
  Center, Düzce, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Saadet Can Cicek, Associate Professor,PhD — Abant Izzet Baysal University
• Study coordinator: Seymanur Ozdemir Arslan, MSc,Phd Candidate
• Email: seymanurarslan@duzce.edu.tr
• Phone: +90 0380 523 7827

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endothelial extracellular vesicles in kids with newly diagnosed high blood pressure

  This study tests whether levels of endothelial extracellular vesicles are different in children with new, untreated primary hypertension compared to normotensive children.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728643

• Dietary nitrate, oral bacteria, and blood pressure in children with primary hypertension

  We will test whether differences in mouth bacteria and how saliva handles dietary nitrate are linked to blood pressure in 10–18-year-olds with primary hypertension compared with healthy peers.

  Recruiting Istanbul University · Istanbul, Fatih · NCT07236125

• Lavender inhalation for anxiety, sleep quality, and blood pressure in people with primary hypertension

  This trial will test whether inhaling lavender oil three times a week for one month can reduce anxiety, improve sleep quality, and affect blood pressure in people with primary hypertension.

  Recruiting Ardahan University · Ardahan, Ardahan · NCT07192783

• SLT versus daily latanoprost to lower eye pressure in early to moderate open‑angle glaucoma and ocular hypertension

  This trial will test whether a one‑time selective laser trabeculoplasty (SLT) or daily 0.005% latanoprost eye drops better lower eye pressure in treatment‑naïve adults with early to moderate primary open‑angle glaucoma or ocular hypertension.

  Recruiting Lagos State Health Service Commission · Ikeja, Lagos · NCT07310719

• Direct selective laser trabeculoplasty to lower eye pressure in untreated open-angle glaucoma

  This study will try direct selective laser trabeculoplasty (DSLT) to lower eye pressure by more than 20% without glaucoma medications over six months in adults newly diagnosed with open-angle glaucoma or ocular hypertension.

  Recruiting Shafer Vision Institute · Plymouth Meeting, Pennsylvania · NCT07076303

• Yufeng Ningxin for High Blood Pressure in Adults

  This study tests whether Yufeng Ningxin tablets can lower blood pressure in adults with essential hypertension compared with a placebo.

  Recruiting at 12 sites Phase 4 Beijing Anzhen Hospital · Beijing and 15 other locations · NCT07607275

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.